Login / Signup

Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B.

Katsuyuki FukutakeKanae TogoLinghua XuLeona E MarksonJosé Maria Jimenez AlvirIan WinburnToshiyuki Karumori
Published in: Journal of blood medicine (2023)
In the real-world setting in Japan, medical expenditures and the proportion of patients prescribed EHL FIX concentrates for the treatment of hemophilia B have increased.
Keyphrases
  • end stage renal disease
  • healthcare
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes